Patheon
Provider of integrated CDMO and CRO services covering drug substance and drug product development, clinical trial services, supply chain and commercial manufacturing across small molecules, biologics, viral vectors, and advanced therapies. Offers end-to-end capabilities including early-stage process development, analytical characterization, GMP manufacturing, regulatory and clinical supply services, and digital supply-chain enablement via a global network of sites.
Industries
Nr. of Employees
Very Large (1000+)
Patheon
Raleigh, North Carolina, United States, North America
Patents
Products
Small Molecule API Manufacturing
Manufacturing and development services for small molecule active pharmaceutical ingredients (APIs) including formulation, analytical testing, and scale-up.
Oral Solid Dose (OSD) Development and Manufacturing
Development and commercial manufacturing of oral solid dose drug products including formulation, process development, and packaging.
Softgel Manufacturing
Manufacturing of softgel capsules to improve drug solubility, bioavailability, and patient compliance for prescription and over-the-counter drugs.
Sterile Drug Development and Manufacturing
Development and commercial manufacturing of sterile drug products including aseptic fill-finish, lyophilization, and high-potency drug handling.
Biologics Development and Manufacturing
Development and manufacturing services for large molecule biologic drugs including cell culture, purification, and aseptic processing.
Advanced Therapy Development and Manufacturing
Development and manufacturing of advanced therapies including viral vectors, cell therapies, and mRNA therapeutics for clinical and commercial use.
Small Molecule API Manufacturing
Manufacturing and development services for small molecule active pharmaceutical ingredients (APIs) including formulation, analytical testing, and scale-up.
Oral Solid Dose (OSD) Development and Manufacturing
Development and commercial manufacturing of oral solid dose drug products including formulation, process development, and packaging.
Softgel Manufacturing
Manufacturing of softgel capsules to improve drug solubility, bioavailability, and patient compliance for prescription and over-the-counter drugs.
Sterile Drug Development and Manufacturing
Development and commercial manufacturing of sterile drug products including aseptic fill-finish, lyophilization, and high-potency drug handling.
Biologics Development and Manufacturing
Development and manufacturing services for large molecule biologic drugs including cell culture, purification, and aseptic processing.
Advanced Therapy Development and Manufacturing
Development and manufacturing of advanced therapies including viral vectors, cell therapies, and mRNA therapeutics for clinical and commercial use.
Services
Integrated drug substance and drug product development, analytical and regulatory support, clinical trial services, and commercial manufacturing delivered through a single coordinated program.
Programs that accelerate early development and IND/CTA readiness via platform processes, rapid analytics, and coordinated cross-functional teams.
Clinical packaging and labeling, comparator sourcing, storage and distribution, and temperature-controlled transportation for clinical and commercial supplies.
Analytical method development, stability testing, solid-state characterization, and single-particle capsid characterization using high-throughput techniques.
Integrated drug substance and drug product development, analytical and regulatory support, clinical trial services, and commercial manufacturing delivered through a single coordinated program.
Programs that accelerate early development and IND/CTA readiness via platform processes, rapid analytics, and coordinated cross-functional teams.
Clinical packaging and labeling, comparator sourcing, storage and distribution, and temperature-controlled transportation for clinical and commercial supplies.
Analytical method development, stability testing, solid-state characterization, and single-particle capsid characterization using high-throughput techniques.
Expertise Areas
- Integrated CDMO/CRO services
- Clinical trial management and logistics
- Small-molecule API development and scale-up
- Oral solid dose formulation and particle engineering
Key Technologies
- Predictive in-silico modeling and simulation
- AI/ML-driven formulation and biologics optimization
- Mass photometry for single-particle capsid analysis
- Continuous manufacturing
News & Updates
Article discussing the importance of route scouting, recrystallization, polymorph screening, and solid-state characterization for scalable early-stage process development.
Overview of mass photometry as a high-throughput approach for AAV capsid characterization and comparison to traditional analytical ultracentrifugation.
Explainer differentiating CROs, CMOs, and CDMOs and outlining when sponsors might choose each model.
Discussion of industry trends including flexible manufacturing, digital enablement, and strategic CDMO partnerships.
Explains use of computational simulation and AI/ML to predict solubility and bioavailability outcomes and to prioritize formulation strategies.
Article discussing the importance of route scouting, recrystallization, polymorph screening, and solid-state characterization for scalable early-stage process development.
Overview of mass photometry as a high-throughput approach for AAV capsid characterization and comparison to traditional analytical ultracentrifugation.
Explainer differentiating CROs, CMOs, and CDMOs and outlining when sponsors might choose each model.
Discussion of industry trends including flexible manufacturing, digital enablement, and strategic CDMO partnerships.
Explains use of computational simulation and AI/ML to predict solubility and bioavailability outcomes and to prioritize formulation strategies.